Feb 26, 2025 / 08:00AM GMT
Tobias Bjorklund - Novozymes A/S-Head of Investor Relations
Thank you very much, operator, and welcome, everyone, to the Novonesis conference call relating to the full year performance of 2024. My name is Tobias Björklund, and as I said, I'm heading up Investor Relations here at Novonesis.
In this call, our CEO, Ester Baiget; and our CFO, Rainer Lehmann, will review our pro forma performance for the year as well as outlook for 2025. Attending today's call, we also have Jacob Paulsen, EVP of Food & Beverage Biosolutions; Amy Byrick, EVP of Human Health Biosolutions; Tina Fanø, EVP of Planetary Health Biosolutions; and Claus Crone Fuglsang, Chief Scientific Officer.
The conference call will take about one hour, including Q&A. Please change to the next slide, and this is to remind you that the information presented during the call is unaudited and that management may make forward-looking statements.
These statements are based on current expectations and beliefs and they involve risks and uncertainties that could cause actual results to
Full Year 2024 Novozymes A/S Earnings Call Transcript
Feb 26, 2025
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers